ACCL1931
OPEN TO ACCRUAL
Ph3 Levocarnitine Prophylaxis for AYA in ALL Therapy
MYELOMATCH
OPEN TO ACCRUAL
MSRP for Tier Advancement in the NCI myeloMATCH Trials
UW19086
OPEN TO ACCRUAL
LTFU Protocol for Subjects Treated with Gene-Modified T Cells
UW23093
OPEN TO ACCRUAL
Ph 1 Study of Venetoclax/Aza or Venetoclax in Combo w/ Ko-539 or 7+3 in combo w/Ko-539 in AML
UW23129
OPEN TO ACCRUAL
Ph1 Dose-Escalation Trial of Mesenchymal Stromal Cells in pts w Medical Xerostomia
UW24000
OPEN TO ACCRUAL
Ph1/3 study on efficacy and safety of selinexor in combo with ruxolitinib in pts w myelofibrosis
UW24056
OPEN TO ACCRUAL
PH1/1b Study of CLK Inhibitor BH-30236 in Adutls with R/R AML or HR-MDS